Tizanidine Tablet
Product Images NDC 63187-145

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63187-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure- Tizanidine HCl (953db236 B848 484f 83b7 436c3a274c88 01)

FDA Label Image

Figure 1 (953db236 B848 484f 83b7 436c3a274c88 02)

FDA Label Image

Figure 2 (953db236 B848 484f 83b7 436c3a274c88 03)

FDA Label Image

Figure 3 (953db236 B848 484f 83b7 436c3a274c88 04)

FDA Label Image

Tizanidine 4mg (953db236 B848 484f 83b7 436c3a274c88 05)

Tizanidine 4mg (953db236 B848 484f 83b7 436c3a274c88 05)
This is a description of a medication packaging for a prescription drug called Tizanidine 4mg. The package comes with 30 tablets and is labeled with the NDC code 63187-145-30. The medication is packaged by Proficient Rx LP from Thousand Oaks, California. Each tablet contains 4.576 mg of tizanidine hydrochloride equivalent to 4 mg of tizanidine base. The tablets are white to off-white, round, and scored, imprinted with “APO" over “Ti-4" on one side and plain with a quadrisect score on the other side. The medication is not interchangeable with Tizanidine NDC 63187-145-30 capsules or Zanaflex capsules. The lot number is 00000 and expiration date is 000000. The package is intended for prescription use only and should be kept out of the reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.